Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.
Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.
Stay tuned for these updates, and thank you for being part of our community!
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03598608 |
Title | Study to Evaluate the Safety and Efficacy of a Combination of MK-4280 and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Merck Sharp & Dohme Corp. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | ITA | ISR | DEU | CAN | AUS |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
Banner MD Anderson Cancer Center ( Site 0020) | Gilbert | Arizona | 85234 | United States | Details | |
City of Hope ( Site 0001) | Duarte | California | 91010 | United States | Details | |
Ronald Reagan UCLA Medical Center (Radiological Sciences) ( Site 0007) | Los Angeles | California | 90095 | United States | Details | |
Pacific Cancer Care ( Site 0006) | Monterey | California | 93940 | United States | Details | |
University of California San Francisco ( Site 0023) | San Francisco | California | 94143 | United States | Details | |
Dana Farber Cancer Institute ( Site 0002) | Boston | Massachusetts | 02215 | United States | Details | |
Fox Chase Cancer Center ( Site 0019) | Philadelphia | Pennsylvania | 19111 | United States | Details | |
Texas Oncology-Austin Midtown ( Site 8002) | Austin | Texas | 78705 | United States | Details | |
Concord Repatriation & General Hospital ( Site 0203) | Concord | New South Wales | 2139 | Australia | Details | |
Princess Alexandra Hospital ( Site 0204) | Woollongabba | Queensland | 4102 | Australia | Details | |
Monash Health ( Site 0201) | Clayton | Victoria | 3168 | Australia | Details | |
St Vincent s Hospital (Melbourne) Limited ( Site 0202) | Fitzroy | Victoria | 3065 | Australia | Details | |
BC Cancer ( Site 0107) | Vancouver | British Columbia | V5Z 1L3 | Canada | Details | |
CancerCare Manitoba ( Site 0101) | Winnipeg | Manitoba | R3E 0V9 | Canada | Details | |
Princess Margaret Cancer Centre ( Site 0100) | Toronto | Ontario | M5G 2M9 | Canada | Details | |
Jewish General Hospital ( Site 0105) | Montreal | Quebec | H3T 1E2 | Canada | Details | |
U. klinikum Koeln AOER ( Site 0326) | Koeln | Nordrhein-Westfalen | 50937 | Germany | Details | |
Universitaetsklinikum Leipzig AOeR ( Site 0327) | Leipzig | Sachsen | 4103 | Germany | Details | |
Rambam Medical Center ( Site 0382) | Haifa | 3109601 | Israel | Details | ||
Hadassah Ein Karem Jerusalem ( Site 0383) | Jerusalem | 9112001 | Israel | Details | ||
Chaim Sheba Medical Center. ( Site 0380) | Ramat Gan | 5262001 | Israel | Details | ||
Sourasky Medical Center ( Site 0381) | Tel Aviv | 6423906 | Israel | Details | ||
A.O. Universitaria Policlinico S. Orsola-Malpighi ( Site 0351) | Bologna | Emilia-Romagna | 40138 | Italy | Details | |
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori ( Site 0354) | Meldola | Forli-Cesena | 47014 | Italy | Details | |
Humanitas-U.O di Oncologia medica ed Ematologia ( Site 0352) | Rozzano | Milano | 20089 | Italy | Details |